In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.
Experts from Lumanity discuss cross-functional alignment of Integrated Evidence Generation Planning (IEGP) from perspectives of strategy, clinical/regulatory, commercial and patient engagement.
As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating RWE and HEOR alongside traditional approaches when planning data generation activities to support new product registration, access, and use.
Medical Affairs is in the unique position to drive health equity through three main roles: catalyser, capabilities enhancer, and cross-functional collaborator, emphasizing the need for deliberate strategies and actions to close health gaps and improve outcomes for underserved populations.
This introduction to implementation science offers Medical Affairs professionals a 4-step scientific approach for accelerating the adoption of evidence-based care into practice.
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
This webinar provides the Medical Affairs community with a differentiated and bold view to drive the future state of Medical Affairs and what “good” looks like regarding the role of Medical Affairs in Clinical Development.
In this on-demand webinar, learn how to shift the paradigm on integrated evidence generation.
This article highlights a collaborative approach to content creation in which insights from MSLs were used to develop concepts for educational tools that were shared with key opinion leaders (KOLs).
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.